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. Chaperones, oxidoreductases and glycosylating enzymes ensure that secretory proteins are properly folded, modified and assembled into multi-protein complexes in the ER before they transit farther downstream in the secretory pathway. Despite the existence of these proteinfolding machines, there is evidence to suggest that at least a third of all polypeptides translocated into the ER fail to satisfy the quality-control mechanisms that ensure proper folding, and for some proteins the success rate is much lower 2 . Given that client proteins of the secretory pathway often carry out crucial signalling functions (for example, polypeptide hormones and cell surface receptors), improperly folded forms are recognized and disposed of by stringent quality-control systems such as ER-associated degradation (ERAD), which removes unfolded proteins to the cytosol for subsequent ubiquitylation and degradation by the 26S proteasome. Moreover, inherited mutations in an individual protein can compromise its folding efficiency and lead to disease from its resulting deficiency. For example, mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), an ion channel transporting chloride across epithelial tissues, disrupt its folding within the ER, leading to cystic fibrosis.
The protein-folding capacity within the ER differs widely among cell types. Specialized secretory cells contain a large, well-developed ER. For example, each β-cell of the endocrine pancreas is capable of synthesizing and secreting up to one million molecules of insulin per minute; in insulin-resistant states, this enormous protein synthetic load becomes even greater 3 . Regardless of the size of their ER, cells seem to perform near the functional limits of their secretory pathway capacity and often face conditions during which the load imposed on the ER protein-folding machinery overwhelms capability, a condition referred to as ER stress. A wide range of cellular perturbations can induce ER stress, including hypoxia, nutrient deprivation, point mutations in secreted proteins that promote misfolding, redox changes and loss of calcium homeostasis with harmful effects to ER-resident calciumdependent chaperones. Therefore, cells have evolved a robust surveillance system to respond to fluctuations of ER homeostasis before they become a threat to survival.
ER stress engages an adaptive signal transduction pathway called the unfolded protein response (UPR). However, irremediable ER stress turns signalling toward a 'terminal UPR' that drives cells into apoptosis. Cell injury due to chronic ER stress is increasingly being recognized as a common contributor to a wide range of prevalent human diseases, including neurodegeneration, diabetes, cancer, stroke, pulmonary fibrosis, viral infections, inflammation , metabolic disorders, and heart disease exploded with the discovery of the three main mammalian UPR sensors IRE1α (endoribonuclease inositol-requiring enzyme 1-alpha), PERK (protein kinase RNA-like endoplasmic reticulum kinase) and ATF6α (activating transcription factor 6) in 1993 8 , 1998 9 and 1999 10 , respectively. The signalling pathways activated downstream of these sensors constitute an adaptive response to allow cells to cope with protein misfolding by temporarily reducing de novo protein synthesis, and improving the folding and clearance capacity of the ER 11 . However, if these adaptive measures are inadequate to resolve ER stress, the mammalian UPR shifts signals toward the engagement of apoptosis 12 . In this section we discuss the main signalling mechanisms involved in the UPR and the downstream consequences in terms of the cellular processes affected.
Detection of misfolded protein species by the three UPR sensors is partly dependent on BiP (also known as GRP78), a key ER chaperone. Under basal conditions, BiP constitutively binds to the luminal domains of the three sensors thus preventing their activation. However, when misfolded proteins accumulate in the ER, BiP strongly binds to their exposed hydrophobic domains, and dissociates from the UPR sensors, thereby priming IRE1α and PERK for oligomerization and auto-transphosphorylation 13 , and revealing an ER export motif in ATF6α (ref. 14) . BiP binding to UPR sensors was recently shown to be independent of its chaperone activity, suggesting an allosteric regulation 15 . The analysis of the ER luminal structure of IRE1p in S. cerevisiae revealed an MHC-like structure 16 that appears to serve as a direct sensing motif that binds to hydrophobic domains of unfolded proteins 17 . A similar model has been proposed 18 for IRE1β, but may not operate for IRE1α based on structural and in vitro analyses 15, [19] [20] [21] . Stress signalling leads to selective activation of downstream cascades ( Fig. 1) , in which active PERK phosphorylates the translation initiation factor eIF2α leading to attenuation of global protein synthesis 22, 23 . Inhibition of eIF2α allows the selective expression of ATF4, a transcription factor controlling genes involved in protein folding, antioxidant responses, autophagy, amino acid metabolism and apoptosis 24, 25 . Moreover, active PERK phosphorylates and activates NRF2, a transcription factor involved in the control of the antioxidant pathway [26] [27] [28] . Finally, ATF6α belongs to a family of transmembrane transcription Foldases Autophagy Apoptosis RESET P P P P Figure 1 The three arms of the UPR. All three ER stress sensors (PERK, IRE1α, ATF6) are present in the ER membrane and initially activate signalling events that increase protein-folding capacity and reduce protein load on the ER. These transcriptional and translational outputs tend to re-establish protein-folding homeostasis in the ER and promote cell survival. PERK phosphorylates eIF2α, which in turn shuts down global translation and concomitantly increases the expression of the transcription factor ATF4. The latter induces the transcription of select genes whose functions are to restore proteostasis and of CHOP, itself inducing the transcription of GADD34, a regulatory subunit of PP1C. This creates a feedback mechanism leading to the dephosphorylation of eIF2α and translation is reinitiated. IRE1α signals through (i) the recruitment of TRAF2 leading the activation of the ASK1-JNK cascade and (ii) through its RNase via the splicing of XBP1 mRNA or the degradation of RNAs (RIDD activity), thereby regulating gene expression at transcriptional and post-transcriptional levels. Finally, following ER stress, ATF6 is exported from the ER to the Golgi complex where it is cleaved by the proteases S1P and S2P, releasing its cytosolic domain which is a potent transcription factor. Together, UPR transcription factors determine cell fate by the regulation of distinct subsets of target genes toward recovery of ER homeostasis or the induction of apoptosis. The grey boxes illustrate the different functions of genes induced by the ER stress response. RESET, rapid ER stress induced export.
factors of about 10 members that function in different ways as stress response elements 29 . Following ER stress, ATF6α is exported from the ER (ref. 10 ) and activated in the Golgi complex through cleavage by the proteases S1P and S2P (ref. 11). The ATF6α cytosolic domain (ATF6f) then translocates to the nucleus where it activates specific transcriptional programs that promote adaptation, including upregulation of ERAD components 30 . Striking advances in understanding IRE1α signalling have been made recently. IRE1α is an ER transmembrane protein with kinase and endoribonuclease (RNase) activities associated with its cytoplasmic tail. In response to luminal activation, IRE1α dimerizes and transautophosphorylates, inducing a conformational change that activates the RNase domain. IRE1α's RNase catalyses the excision of a 26-nucleotide intron within the XBP1 mRNA, shifting the reading frame to translate a stable and active transcription factor known as XBP1s (refs 31-34) . XBP1s controls genes involved in protein folding, secretion, ERAD and lipid synthesis [35] [36] [37] . In addition, XBP1s may heterodimerize with ATF6f to control distinct gene expression patterns 38 . The unspliced XBP1u protein may regulate the efficient delivery of its mRNA to the ER for processing 39, 40 , in addition to controlling the degradation of XBP1s 41, 42 . IRE1α is involved in the degradation of RNAs (known as regulated IRE1-dependent decay or RIDD) 43 , including ER-localized mRNAs [44] [45] [46] , ribosomal RNA 47 and microRNAs 48, 49 . New insights into the mechanisms regulating IRE1α's switch from XBP1 mRNA splicing to RIDD have been recently reported. IRE1α's RNase substrate specificity can be controlled by its oligomeric state 50 . When IRE1α exists in lower order oligomers (for example, dimers/tetramers), its RNase activity is largely restricted to XBP1 splicing. However, under high or chronic ER stress, IRE1α surpasses an oligomerization threshold that expands its RNase substrate repertoire to many ER-localized mRNAs, leading to RIDD. In contrast to this view, a recent study suggested that XBP1 mRNA splicing requires obligate IRE1α oligomers, but that IRE1α dimers suffice for RIDD (ref. 51) . This is consistent with the idea that RIDD activity can be observed at basal levels in certain systems 43 . Of note, this later report was largely restricted to in vitro analyses of IRE1α activity under saturating protein concentrations, which do not mimic the continuum of IRE1α oligomerization states that likely exist in vivo. However, this model is also supported by cell-based studies in which peptide-induced IRE1 high order oligomers correlated with enhanced IRE1-mediated XBP1 mRNA splicing and reduced RIDD (ref. 52) . Furthermore, IRE1α RNase activity was also linked to its phosphorylation status with key residues involved (that is, Ser724); where other phosphorylation sites mediate its inactivation in yeast 53, 54 . However, the remaining identified phosphorylation sites
have not yet been functionally tested 55 . Very recently, the missing link in IRE1α-mediated XBP1 mRNA splicing was uncovered. Whereas the S. cerevisiae ligase responsible for HAC1 mRNA (the yeast equivalent of XBP1) ligation was identified in 2008 56 , the mammalian counterpart remained unknown. Four studies [57] [58] [59] [60] have now uncovered the nature of the ligase as the tRNA ligase RtcB and demonstrated its physiological role in plasma cell differentiation 57 . Together, these discoveries shed light on the activation and signalling mechanisms of the three UPR sensors and on the biological networks that could be involved in their regulation.
The main biological consequences of UPR activation are the recovery of ER proteostasis (adaptive response) and the induction of a terminal UPR (apoptotic phase). One of the first responses to ER homeostasis imbalance involves global translational attenuation to reduce entry of newly synthesized proteins into the ER. This is in part achieved through PERK-mediated phosphorylation of eIF2α but also through RIDD of mRNAs encoding secretory proteins or ribosomal RNAs. A general mechanism leading to translation shutdown was also uncovered that results in massive detachment of translating ribosomes from the ER membrane upon ER stress 61 . Another safeguard set in place by the ER to alleviate stress involves an increased clearance of misfolded proteins. Although this has been shown to be controlled by ERAD and autophagy 62, 63 , a recent study demonstrated that misfolded GPI-anchored proteins can escape ER retention and translocate to the plasma membrane where they are then degraded by the lysosomal pathway 64 . Finally, in order to re-establish homeostasis within the ER lumen, ER stress also leads to the activation of amino acid metabolism and improvement of antioxidant responses, in addition to the reinforcement of folding and quality-control mechanisms 65 . These events reduce the misfolding burden on the ER thereby allowing the organelle to recover homeostasis.
Cell death control under ER stress
When the buffering capacity of the UPR proves inadequate to restore ER proteostasis, the pathway alternates its signalling towards a terminal UPR (ref. 66) . Although the molecular details are still being solved and may differ depending on cell type, accumulating evidence suggests that a distinct program of pro-apoptotic signals activate the cell death machinery if ER stress cannot be remedied (Fig. 2) 12,67
. For example, although a temporary halt in protein translation due to eIF2α phosphorylation can be advantageous for cells under ER stress, a prolonged block in translation from sustained PERK activation is incompatible with survival. Under chronic ER stress, persistent PERK signalling upregulates the transcription factor CHOP (also known as GADD153), which inhibits expression of the anti-apoptotic BCL-2 to promote cell death 68, 69 . Moreover, it has been shown that CHOP and ATF4 cooperate to transcriptionally activate targets that enhance protein synthesis, and contribute to cell death through reactive oxygen species (ROS) production and ATP depletion 70 . PERK activation may also increase expression of death receptor 5 (DR5) to trigger caspase-8 induced cell death 71 . As mentioned above, chronic ER stress causes IRE1α to transition from a homodimeric state into higher order oligomeric structures, which appears to be the critical step in switching to its apoptotic program 50 . Sustained RIDD activity might deplete protein-folding components to further worsen ER stress 46 . IRE1α also induces the activation of a number of pro-inflammatory and pro-death proteins. For example, the RNase activity of IRE1α decreases the levels of select microRNAs that normally suppress pro-apoptotic targets such as pro-oxidant protein TXNIP (thioredoxin-interacting protein) and caspase-2, leading to their upregulation 48, 49 . Increased TXNIP then activates the inflammasome and caspase-1 48 . Finally, under sustained engagement, IRE1α assembles into an activation platform for apoptosis signal-regulating kinase 1 (ASK1) and its downstream target c-Jun NH 2 -terminal kinase (JNK) 72, 73 . Many of the pro-death signals emerging from UPR sensors ultimately regulate the canonical mitochondrial apoptotic pathway. This pathway is initiated when pro-apoptotic mitochondrial proteins, such as cytochrome c, are actively released into the cytoplasm to trigger the proteolytic activation of effector caspases such as caspase-3. Pro-and anti-apoptotic proteins of the BCL-2 family govern the intrinsic apoptotic pathway by regulating the permeability of the outer mitochondrial membrane 74 . This pathway is set in motion when cell injury is sensed and leads to the transcriptional upregulation and/or post-translational activation of one or more BH3-only proteins, a collection of pro-death proteins all containing a short alpha helix known as the BCL-2 homology 3 (BH3) domain that is necessary for their killing activity 74, 75 . Once activated, BH3-only proteins bind to and neutralize mitochondrialprotecting proteins (for example, BCL-2, BCL-X L and MCL-1) and in some cases directly engage pro-apoptotic BAX and BAK proteins, causing their homo-oligomerization and resultant permeabilization of the outer mitochondrial membrane.
The terminal UPR can activate at least four distinct BH3-only proteins (BID, BIM, NOXA and PUMA) that then signal mitochondrial apoptosis 66 . As such, triple-knockout cells that are deficient in BIM, PUMA and BID are much more resistant to ER stress than cells deficient in any one BH3-only protein 76 , a phenotype resembling a BAX and BAK double deficiency 77 . Each of these BH3-only proteins seems to be activated by ER stress in a unique way 66 . However, it remains unclear if these BH3-only proteins are simultaneously engaged by all forms of severe ER stress or if only a subset can be activated under specific insults. Another group of ancient cell death regulators, known as the TMBIM or the Bax-inhibitor 1 (BI-1) family 78 , also has relevant activities against ER stress (that is, BI-1, also known as TMBIM6, and GRINA, also known as TMBIM3), possibly through the modulation of ER calcium release by the IP 3 receptors 79, 80 . Although multiple mechanisms mediating ER stressinduced apoptosis are available, their individual impact on cell viability is partial, suggesting that combinatorial mechanisms or so called cell death networks control apoptosis when the ER is irreversibly damaged 67 .
Cell fate decisions under ER stress
The UPR operates as a highly dynamic signalling network that integrates information about the intensity and duration of the stress stimuli and possibly the type of perturbation to the secretory pathway. Depending on the experimental system, distinct UPR branches operate independently 
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Cytochrome c release Figure 2 Under irremediable ER stress, the UPR actively promotes proteotoxicity, inflammatory responses and apoptosis. When exposed to chronically high levels of ER stress, PERK (pathway components in blue) and IRE1α (pathway components in green) both lead to cell dysfunction, activation of the inflammasome, and apoptosis (input and outcome depicted in red) through multiple signalling outputs. Among the ATF4 targets downstream of PERK (see Fig. 1 ) are also genes whose products are involved in the control of cell death (DR5 or BH3-only proteins) through the activation of signalling pathways from the plasma membrane or the mitochondria involving activation of BCL-2 family members BAX and BAK and release of apoptogenic factors such as cytochrome c. Similarly, IRE1α signals through the JNK and mRNA/ miRNA degradation pathways to control cell survival. Interestingly, crosstalk between IRE1α and PERK signalling at the level of DR5, tightly control cell fate. ER calcium release also contributed to ER stress-mediated cell death, possibly involving IP3 receptors and the expression of TMBIM family members such as BI-1, which also inhibits IRE1α signalling. Overload of calcium leads to the activation of the permeability transition pore (PTP), triggering the release of cytochrome c and the activation of downstream caspases.
in terms of their activation pattern, signalling kinetics and downstream output signals. In this section, we discuss recent advances in defining how the UPR is fine-tuned, and its impact on determining the transition from adaptive to pro-apoptotic programs. Analysis of the signalling kinetics of the three main UPR sensors has revealed that the temporal activation of each branch can vary depending on the nature of the pharmacological stressor used to perturb ER function 81, 82 . Moreover, ATF6α can be selectively activated by the overload of the ER lumen with proteins 83 , and its activity is also specifically modulated by its N-glycosylation state and the redox status of the ER (ref. 84, 85) . In addition, depending on the intensity of the stress, the signalling outputs of the UPR differ. Indeed low concentrations of ER stress agents engage all UPR signalling branches to initiate adaptive outputs, whereas high levels of ER stress results in apoptotic signals 86 . This is consistent with the observation that certain specialized secretory cells, such as pancreatic β-cells and B lymphocytes, are normally able to function under sustained levels of physiological ER stress without apoptosis induction 87 . The differential modulation of UPR signalling may underlay the mechanism behind the integration of global responses toward proteostasis recovery and the threshold to induce apoptosis. Despite the fact that the ER-sensing domains of IRE1α and PERK have similar primary structure, and are functionally interchangeable 88 , the temporal pattern of their signalling drastically differs depending on the experimental setting. Under prolonged ER stress, XBP1 mRNA splicing is diminished, whereas PERK signalling is maintained leading to the expression of downstream pro-apoptotic components. This may also contribute to apoptosis by attenuating the survival effects of XBP1s, thus sensitizing cells to ER stress. Besides, PERK-induced CHOP expression could also upregulate GADD34, a component of the eIF2α phosphatase complex that reverts translational inhibition, triggering oxidative stress and proteotoxicity 69, 89 . In other experimental settings, the sustained activation of IRE1α occurs under high ER stress to trigger cell death 43, 46, 50 . Using single cell imaging, a recent report also suggested that the relative kinetics of PERK and IRE1α signalling determines the induction of apoptosis rather than a switch between both branches 90 . These observations emphasize the highly dynamic and complex nature of the UPR regulatory network.
Given that the ER sensing domains of IRE1α and PERK are similar, the temporal behaviour of UPR signalling may be in part mediated by intrinsic conformational changes of the sensors, post-translational modifications and/or the binding to specific positive and negative regulators (Fig. 3) . Most of the studies addressing the molecular basis of finetuning UPR activity have been performed with IRE1α. The concept of the 'UPRosome' envisions IRE1α as a scaffold where many components assemble to selectively regulate its activity (amplitude and kinetics) and the control of specific downstream signals (Fig. 3a ) 91 . IRE1α activation and inactivation are instigated by a direct binding of several factors to the UPRosome that modulate the amplitude of UPR responses without affecting PERK (ref. 92) . Interestingly, many regulators of IRE1α have relevant roles in apoptosis 93 , including members of the BCL-2 family such as BAX, BAK (ref. 94) , some BH3-only proteins 95 , components of the MAP kinase pathway [96] [97] [98] , and its negative regulator BI-1 99, 100 . Although the list of IRE1-binding partners is increasing and a few screens have been recently reported, systematic interactome studies are still missing. Here we highlight recent discoveries of interacting proteins that modulate the sustained signalling of IRE1α under prolonged ER stress. N-MYC Interactor (NMI) protein is an IRE1α-binding partner identified through an interactome screen, which selectively enhances JNK activation and apoptosis, but does not affect XBP1 mRNA splicing 101 . Another proteomic screen also found non-muscle myosin heavy chain IIB (NMIIB), and possibly actin cytoskeleton, as a specific regulator of IRE1α clustering (Fig. 3a) , without affecting its dimerization and phosphorylation process 102 ; a mechanism also validated in yeast 103 . Furthermore, specific protein complexes may be assembled at the level of the IRE1α ER luminal domain. BiP has been known for more than a decade 13 to operate as a negative regulator of IRE1α. The disulphide isomerase PDIA6 was recently shown to control activation and/or inactivation of IRE1α signalling through a direct binding 104, 105 . Hence, IRE1α signalling is fine-tuned by the assembly of distinct signalling complexes at the level of its cytosolic and ER-luminal regions.
Recent discoveries also indicate that PERK and ATF6 are regulated through the binding of specific factors (Fig. 3a,b) . For example, the kinase activity of PERK is selectively reduced by the binding of p58IPK (ref. 106 ), a regulation antagonized by a cytosolic variant of BiP known as GRP78va (ref. 107 ). An interactome analysis identified transducin β-like 2 (TBL2) as a protein that associates with phosphorylated PERK under stress conditions, determining optimal signalling to drive ATF4 expression and stress mitigation 108 . The small GTPase Rheb also bind s and activates PERK, repressing protein translation 109 . Finally, PDIA6 also binds to PERK and negatively modulates the decay of its signalling 104 . In the case of ATF6α, a few direct regulators have been reported such as Wolfram syndrome 1 (WFS1), which mediates the degradation of ATF6 by the proteasome 110 . Since the reduction of intra-and interluminal disulphide bonds in ATF6α modulate its translocation to the Golgi, a cell-based RNAi screen was performed to target most PDIs and ER oxidoreductases 111 . This study identified PDIA5 as a selective and critical regulator of ATF6α activation. Overall, these novel studies highlight the concept that all UPR branches are modulated by protein-protein interactions through the assembly of dynamic complexes or UPRosomes that control the amplitude and temporal behaviour of their signalling.
Although less explored, the UPR is also fine-tuned by post-translational modifications at the level of ER sensors and transcription factors. In the context of glucose metabolism, IRE1α function is directly instigated through the phosphorylation of Ser724 by PKA (ref. 112). IRE1α phosphorylation is attenuated by different phosphatases, including PP2A (ref. 113 ) and PPM1 (refs 114,115) , which were identified through proteomic screens. Protein tyrosine phosphatase-1B (PTP-1B) also has a selective effect on bursting IRE1α signalling 116 . Moreover, ADP-ribosylation of PERK and IRE1α enhances their activities (Fig. 3a,b) 
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, and IRE1α ubiquitylation is mediated by the E3 ligase CHIP, which increases JNK signalling without affecting XBP1 mRNA splicing 118 . p38MAPK phosphorylates ATF6α (ref. 119 ) and XBP1s (ref. 120) , having a positive effect on gene expression. XBP1s activity is also modulated by acetylation and sumoylation 121, 122 . Moreover, the association of ATF6f, ATF4 and XBP1s with other transcription factors determines the establishment of stimuliand tissue-specific transcriptional patterns 92, 123 . In agreement with this concept, genome-wide transcriptional profiling under ER stress indicated that the genetic background highly influences the pattern of gene regulation 124, 125 . Finally, non-sense mediated RNA decay also determines the threshold of stress necessary to activate the UPR (refs 126,127) , in addition to adjusting the amplitude of downstream responses and the termination phase by controlling the mRNA stability of UPR components 128 . These observations highlight the dynamic crosstalk between mRNA metabolism and the proteostasis network. These examples illustrate that the strength and temporal activation/inactivation of each UPR signalling arm is independently regulated at different stages depending on the stress condition and the tissue/cell type affected.
Although our understanding of how the UPR network is regulated is constantly growing, the mechanisms underlying the integration of the stress intensity and its duration are not well described. It is becoming clear that the assembly of UPRosome regulatory complexes determines the threshold of activation of UPR sensors and modulates the final outcome of the pathway. One of the major limitations in the field is the fact that most studies rely on the use of acute stressors that irreversibly damage the ER, leading to apoptosis. These 'non-physiological' conditions normally trigger the upregulation of pro-survival and pro-apoptotic components with virtually identical kinetics. Importantly, an approach was recently developed to model 'resolvable' ER stress, leading to full activation of the adaptive UPR in the absence of apoptosis features 129 . Using this approach, a signalling crosstalk was discovered that mediates adaptation to ER stress involving oestrogen signalling 129 . We believe these technological advances will enable the examination of cell fate mechanisms under ER stress in a tractable system.
Novel functions of the UPR Secreted factors can control extracellular proteostasis. There is a continuum between the ER lumen and the extracellular space; and stressed cells have developed ways to control their microenvironment by secreting key enzymes. The most recent example of this mechanism is illustrated by the secretion of ERdj3, which extracellularly binds misfolded proteins, inhibits their aggregation and attenuates proteotoxicity of disease-associated prion protein 130 . Similarly, enforced expression of XBP1s or ATF6α in a stress-independent manner reduces extracellular aggregation of amyloidogenic immunoglobulin variants 131 . Other chaperones of the GRP and PDI family are also secreted through a regulatory mechanism dependent on ER stress 132 . This phenomenon is also observed with redox proteins such as QSOX1, which controls the structure of the extracellular matrix 133 most likely in conjunction with secreted PDI family members such as ERp57 (ref. 134) .
Stress-independent functions of the UPR have been identified. The crosstalk between plasma membrane signalling and the ER is illustrated by cell surface receptors and UPR components (Fig. 4a) . In macrophages, optimal secretion of pro-inflammatory cytokines by Toll-like receptors (TLR) is mediated by XBP1, where TLR stimulation engages IRE1α in the absence of global ER stress markers, possibly mediated by NADPH oxidase 2 signalling 135 . Moreover, TLR signalling may even signal to repress ATF4-CHOP expression 136, 137 . Similarly, the well-known function of XBP1s in plasma cell differentiation 138 may occur in a stress-independent manner, initiated by the signalling of B cell receptor to control cell differentiation programs 139 . In agreement with this concept, XBP1 modulates the activity of MIST1, a master regulator of cell differentiation in different cell types 140 . IRE1α has been also proposed to monitor fluctuation in glucose levels in the absence of ER stress, mediated by its phosphorylation, occuring independently of the release of BiP from the luminal domain 113, 141 . Similarly, CD40 signalling increases XBP1 mRNA splicing and thus protects the secretory pathway of hepatocytes from ER stress induced by either tunicamycin or oleic acid 142 . In endothelial cells, VEGF activates all UPR mediators via signalling through a PLCγ-mediated crosstalk with mTORC1 in an ER stress-independent manner, contributing to endothelial cell survival and angiogenesis 143 . Thus, UPR signalling modules may have important cellular functions unrelated to ER stress.
Functional and physical connections between the ER and mitochondria have long been described in the literature, especially in the field of apoptosis and in mitochondrial dynamics. PERK is located at mitochondrial associated membranes (MAMs), where it is required to maintain the ER-mitochondria juxtapositions and the production of ROS to engage mitochondrial-dependent apoptosis 144, 145 (Fig. 4b) . These observations were associated with a physical interaction between PERK and the ER tethering protein mitofusin 2 (ref. 145) . Interestingly, mitofusin 2 deficiency leads to chronic ER stress 146 . IRE1α has been also detected in MAMs 147 , and might contribute to apoptosis by modulating calcium transfer and ROS production by the mitochondria 148 . Obesity leads to a marked reorganization of MAMs in the liver, resulting in mitochondrial calcium overload and compromised mitochondrial oxidative capacity 149 . Whether the localization of UPR stress sensors at MAMs affects mitochondrial bioenergetics and its dynamics remains an open question.
Classically, the mechanisms controlling responses to altered proteostasis are considered 'cell intrinsic' (also termed cell-autonomous). Recent studies in the field have provided evidence for regulation of stress responses at a distance, largely mediated by the nervous system, on a cell-nonautonomous manner 150 . One of the first examples for cell-nonautonomous control of the UPR came from aging studies in Caenorhabditis elegans. Enforced expression of XBP1s in neurons increases life span of this model organism 151 . Remarkably, neuronal XBP1s is able to promote IRE1α activation and XBP1 mRNA splicing in peripheral tissues, and this stress signalling propagation was crucial to protect against aging 151 . An analogous cell-nonautonomous regulatory circuit was only recently uncovered in mammals where hypothalamic XBP1s expression modulates global metabolism through a cell-nonautonomous propagation of UPR signals to the liver 152 (Fig. 4c) . In all these studies, whether the activation of the UPR in the distant cell is ER-stress-independent remains to be clarified. The activation of a cell-nonautonomous UPR is emerging as an evolutionary conserved mechanism to prevent uncontrolled protein misfolding on an organismal level. Thus, the UPR may be also fine-tuned at the level of complex tissues and even the whole organism.
Concluding remarks
The UPR is a conserved signal transduction pathway activated when cells fail to keep up with the protein folding demands on the ER. In response to mild ER stress, the UPR promotes adaptive outputs that reduce unfolded protein load and improve the ability of the secretory pathway to restore proteostasis. However, under irreversible ER stress, the UPR assembles into an alternate platform that engages a complex network of signals to hasten cell demise. Cell injury due to ongoing ER stress has emerged as a central contributor to the pathophysiology of a wide range of common human diseases and aging. Recent advances in our knowledge of how the UPR shifts from life-to-death signalling, and the development of small molecule inhibitors of the UPR (ref. 153) , are the stepping stones for new strategies to combat these ER stress-associated diseases. Despite the immense progress made over the past decade into the biological relevance of the UPR, many questions remain open. The next few years promise to shed much needed light on the coordination and specific contribution of the three arms of the UPR in health and disease; what role each plays in the absence of ER stress; and how they are regulated at the whole-organism level. Many novel stress-independent functions of UPR signalling modules are also emerging as relevant contributors to cell physiology and disease, which may involve allosteric and post-translational modifications to stress sensors through the assembly of distinct UPRosome complexes. It is becoming clear that this field is gaining complexity each year and that the UPR can no longer be viewed as a linear pathway, as multiple modulatory steps and dynamic crosstalk operate to integrate the UPR with the global proteostasis network and other relevant signalling pathways.
